0000810084-13-000002.txt : 20130128
0000810084-13-000002.hdr.sgml : 20130128
20130128202222
ACCESSION NUMBER: 0000810084-13-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20130128
FILED AS OF DATE: 20130128
DATE AS OF CHANGE: 20130128
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: BIOJECT MEDICAL TECHNOLOGIES INC
CENTRAL INDEX KEY: 0000810084
STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841]
IRS NUMBER: 931099680
STATE OF INCORPORATION: OR
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 20245 SW 95TH AVENUE
CITY: TUALATIN
STATE: OR
ZIP: 97062
BUSINESS PHONE: 5036928001
MAIL ADDRESS:
STREET 1: 20245 SW 95TH AVENUE
CITY: TUALATIN
STATE: OR
ZIP: 97062
FORMER COMPANY:
FORMER CONFORMED NAME: BIOJECT MEDICAL SYSTEMS LTD
DATE OF NAME CHANGE: 19920703
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: FLYNN EDWARD L
CENTRAL INDEX KEY: 0001031599
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-15360
FILM NUMBER: 13553328
MAIL ADDRESS:
STREET 1: 211 SOMERVILLE ROAD RTE 202N
CITY: BEDMINISTER
STATE: NJ
ZIP: 07921
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2013-01-28
0
0000810084
BIOJECT MEDICAL TECHNOLOGIES INC
BJCT
0001031599
FLYNN EDWARD L
7180 SW SANDBURG STREET
SUITE 100
TIGARD
OR
97223
1
0
0
0
Warrant to Purchase Common Stock
0.19
2011-12-29
4
P
0
26316
0
A
2011-12-29
2014-06-28
BJCT Common Stock
26316
52632
D
Warrant to Purchase Common Stock
0.19
2013-01-24
4
D
0
52632
0
D
2013-01-24
2013-01-24
BJCT Common Stock
52632
0
D
Series H Convertible Preferred Stock
0.035
2013-01-24
4
P
0
3794857
0.035
A
2013-01-24
BJCT Common Stock
3794857
5072557
D
Cancellation of Warrants pursuant to Convertible Debt conversion into 13,282 Series H Preferred Stock.
No expiration date.
Holdings: 7,842 shares of Series F Preferred Stock convertible into 784,200 shares of Common Stock; 4,935 shares of Series G Preferred Stock convertible into 493,500 shares of Common Stock; 13,282 shares of Series H Preferred Stock convertible into 3,794,857 shares of Common Stock.
//Christine M. Farrell Attorney-in-Fact for Edward L.Flynn//
2013-01-28